A Phase 2/3 Open-Label, Single-Arm Trial to Evaluate the Safety and Activity of Eculizumab in Pediatric Patients with Relapsing Neuromyelitis Optica Spectrum Disorder

Administered By

Pediatrics, Rheumatology

Awarded By

Alexion Pharmaceuticals, Inc.

Contributors

Van Mater, Heather Ann Principal Investigator

Start/End

November 16, 2020 - November 30, 2022